• Home
  • Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.

Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.

Author List
O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ
Publication
The Prostate
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1425741
Publication Year
2002
PubMed ID
11757033